Deep Vein Thrombosis clinical trials at University of California Health

5 in progress, 4 open to eligible people

Showing trials for

  • BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis

    open to eligible people ages 18 years and up

    The objective of this study is to demonstrate the safety and efficacy of the Indigo Aspiration system for percutaneous mechanical thrombectomy in a population presenting with obstruction due to deep vein thrombosis (DVT) who are eligible for treatment.

    at UCLA

  • Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

    open to eligible people ages 18 years and up

    The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severity and improve quality of life in patients with established disabling iliac-obstructive post thrombotic syndrome (DIO-PTS).

    at UCLA UCSF

  • DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

    open to eligible people ages 18 years and up

    This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

    at UC Irvine

  • JETi Peripheral Thrombectomy Registry

    open to eligible people ages 18 years and up

    The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi® Peripheral Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers in the US and Europe. Subjects participating in this registry will be followed through their 12-month follow up visit.

    at UCLA

  • ClotTriever Outcomes (CLOUT) Registry

    Sorry, in progress, not accepting new patients

    Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.

    at UCLA

Our lead scientists for Deep Vein Thrombosis research studies include .

Last updated: